Confounding by indication limits conclusions of study of palivizumab effectiveness

Thomas G. Boyce; Ram Yogev; John P. DeVincenzo; Leonard R. Krilov

doi:10.1542/peds.2016-4247A

Confounding by indication limits conclusions of study of palivizumab effectiveness

Thomas G. Boyce, Ram Yogev, John P. DeVincenzo, Leonard R. Krilov

Pediatrics

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English (US)
Article number	e20164247A
Journal	Pediatrics
Volume	139
Issue number	3
DOIs	https://doi.org/10.1542/peds.2016-4247A
State	Published - Mar 2017

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1542/peds.2016-4247A

Cite this

@article{eb260c53e18d4ca0a50e20c7dc68738c,

title = "Confounding by indication limits conclusions of study of palivizumab effectiveness",

author = "Boyce, {Thomas G.} and Ram Yogev and DeVincenzo, {John P.} and Krilov, {Leonard R.}",

year = "2017",

month = mar,

doi = "10.1542/peds.2016-4247A",

language = "English (US)",

volume = "139",

journal = "Pediatrics",

issn = "0031-4005",

publisher = "American Academy of Pediatrics",

number = "3",

}

TY - JOUR

T1 - Confounding by indication limits conclusions of study of palivizumab effectiveness

AU - Boyce, Thomas G.

AU - Yogev, Ram

AU - DeVincenzo, John P.

AU - Krilov, Leonard R.

PY - 2017/3

Y1 - 2017/3

UR - http://www.scopus.com/inward/record.url?scp=85015979332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015979332&partnerID=8YFLogxK

U2 - 10.1542/peds.2016-4247A

DO - 10.1542/peds.2016-4247A

M3 - Letter

C2 - 28246350

AN - SCOPUS:85015979332

SN - 0031-4005

VL - 139

JO - Pediatrics

JF - Pediatrics

IS - 3

M1 - e20164247A

ER -

Confounding by indication limits conclusions of study of palivizumab effectiveness

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this